You can buy or sell Vor Biopharma and other stocks, options, and ETFs commission-free!
Vor Biopharma Inc. Common Stock, also called Vor Biopharma, is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours